1. 662PBiomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER2+ gastric adenocarcinoma (GEA). (23rd October 2018) Authors: Catenacci, D V T; Park, H; Uronis, H E; Kang, Y-K; Ng, M; Gold, P; Lacy, J; Enzinger, P C; Park, S; Lee, K-W; Yen, J; Odegaard, J; Franovic, A; Baughman, J; Muth, J; Wynter-Horton, A; Wu, T; Wigginton, J; Davidson-Moncada, J K; Bang, Y-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LIGO detector characterization in the second and third observing runs. (3rd June 2021) Authors: Davis, D; Areeda, J S; Berger, B K; Bruntz, R; Effler, A; Essick, R C; Fisher, R P; Godwin, P; Goetz, E; Helmling-Cornell, A F; Hughey, B; Katsavounidis, E; Lundgren, A P; Macleod, D M; Márka, Z; Massinger, T J; Matas, A; McIver, J; Mo, G; Mogushi, K Journal: Classical and quantum gravity Issue: Volume 38:Number 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0027 Immunomodulatory effects of MGD010, a dart® molecule targeting human B-CELL CD32B and CD79B. (15th June 2017) Authors: Chen, W; Shankar, S; Lohr, J; Yao, X-T; Li, H; Chen, X; Muth, J; Gal-Edd, N; Bonvini, E; Johnson, S; Pandya, N; Moore, PA; Wigginton, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗